NIOSH Drafts New Universal Test Protocol for Closed System Transfer Devices
NIOSH will hold a public meeting on Nov. 7 to provide an update on a new universal performance test protocol for closed system transfer devices (CSTDs) used during pharmacy compounding and the administration of hazardous drugs. CSTDs are intended to prevent workers from being exposed to dangerous levels of drugs when transferring them from one container to another. They also prevent sterile drugs from being contaminated. According to NIOSH, CSTDs are generally available in two design types: one design uses a physical barrier to prevent the release of hazardous drugs from the closed system, and the second design uses air-cleaning or filtration technologies to accomplish the same. NIOSH’s new proposed draft protocol is applicable to both barrier and air-cleaning types of CSTDs.
The meeting will cover the proposed list of hazardous drug test surrogates, benefits, and challenges in developing the universal test protocol. The public will also have the opportunity to comment and answer NIOSH’s questions related to the new draft protocol.
For more information about submitting comments, see the Federal Register notice. Electronic or written comments must be received by Dec. 7, 2016.